Drug Pipeline

RAP-219 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Phase 3

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-05	NCT07594119 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal…	Recruitment opened
2026-05-16	NCT07563881 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal…	Recruitment opened

New Trial Filings, Last 30 Days

First Posted	Trial	Phase	Status
2026-05-18	NCT07594119 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal…	Phase 3	Recruiting

Active Studies by Phase

Phase 3

Phase 2

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT07563881	Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal…	Focal Seizure	Recruiting
NCT07594119	Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal…	Focal Seizure	Recruiting
Phase 2
NCT07219407	A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset…	Focal Epilepsy	Recruiting
NCT07046494	Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I…	Bipolar 1 Disorder	Recruiting

Sponsors Running RAP-219 Trials

Rapport Therapeutics Inc. (4)

Disease Areas

Epilepsy (3) Bipolar Disorder (1)

Get alerts when RAP-219 trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.